Document Detail

Gabapentin in the treatment of refractory partial epilepsy in children with intellectual disability.
MedLine Citation:
PMID:  10030434     Owner:  NLM     Status:  MEDLINE    
Twenty-six children with intellectual disability and six normal children, all suffering from refractory partial seizures, received open-label gabapentin (range = 10-50 mg kg(-1) day(-1); mean = 26.7 mg kg(-1) day(-1) as an add-on medication to their antiepileptic drug regimen. Mean seizure frequency during baseline was 9.5 seizures per week. Both groups had a significant reduction in seizure frequency. Response scores and response ratios did not differ between the intellectually disabled and normal groups (1.67+/-0.67 and 1.25+/-0.69, P = 0.697, and -0.400+/-0.089 and -0.283+/-0.159, P = 0.961, respectively). Behavioural side-effects were more likely to occur in patients with intellectual disability in comparison with the mentally normal group (P = 0.0107). In the present patient population, patients younger than 10 years of age, all of whom had intellectual disability, were more likely to have side-effects than those older than 10 years of age. Observed adverse effects, which were generally mild, occurred in patients with baseline intellectual disability, attention deficit disorder and behavioural problems. Behavioural adverse effects warranted discontinuation of the medication in only three patients. The severity of intellectual disability (mild versus moderate or severe) did not affect the extent of the response or the occurrence of side-effects. It is concluded that gabapentin is equally effective as an add-on medication against partial seizures in patients with or without intellectual disability. However, children with intellectual disability who also are less than 10 years of age with baseline attention deficit appear to be at a higher risk of behavioural side-effects.
M A Mikati; R Choueri; D S Khurana; J Riviello; S Helmers; G Holmes
Related Documents :
740484 - Laterality preference patterns of learning disabled children.
18647374 - Dental discomfort questionnaire: its use with children with a learning disability.
7057164 - Self-instruction and learning disabilities: maintenance, generalization, and subject ch...
9544354 - The sensory profile: a discriminant analysis of children with and without disabilities.
19892364 - Phthalate exposure and precocious puberty in females.
6951244 - Effect of intensive treatment with chlorhexidine on number of streptococcus mutans in s...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Journal of intellectual disability research : JIDR     Volume:  42 Suppl 1     ISSN:  0964-2633     ISO Abbreviation:  J Intellect Disabil Res     Publication Date:  1998 Dec 
Date Detail:
Created Date:  1999-06-01     Completed Date:  1999-06-01     Revised Date:  2013-06-11    
Medline Journal Info:
Nlm Unique ID:  9206090     Medline TA:  J Intellect Disabil Res     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  57-62     Citation Subset:  IM    
Department of Pediatrics, American University of Beirut, Lebanon.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acetates / adverse effects*
Anticonvulsants / adverse effects*
Child, Preschool
Cyclohexanecarboxylic Acids*
Epilepsies, Partial / complications*,  drug therapy*
Intellectual Disability / complications*,  diagnosis
Retrospective Studies
Severity of Illness Index
gamma-Aminobutyric Acid*
Reg. No./Substance:
0/Acetates; 0/Amines; 0/Anticonvulsants; 0/Cyclohexanecarboxylic Acids; 56-12-2/gamma-Aminobutyric Acid; 6CW7F3G59X/gabapentin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Lamotrigine in the treatment of epilepsy in people with intellectual disability.
Next Document:  Tiagabine: a new therapeutic option for people with intellectual disability and partial epilepsy.